Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

IF 1.4 Q4 ONCOLOGY
Pleura and Peritoneum Pub Date : 2022-04-26 eCollection Date: 2022-06-01 DOI:10.1515/pp-2021-0150
Jolene Si Min Wong, Grace Hwei Ching Tan, Sabrina Hui Xian Cheok, Chin-Ann Johnny Ong, Claramae Shulyn Chia, Melissa Ching Ching Teo
{"title":"Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.","authors":"Jolene Si Min Wong,&nbsp;Grace Hwei Ching Tan,&nbsp;Sabrina Hui Xian Cheok,&nbsp;Chin-Ann Johnny Ong,&nbsp;Claramae Shulyn Chia,&nbsp;Melissa Ching Ching Teo","doi":"10.1515/pp-2021-0150","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Peritoneal cancer index (PCI) score is a common prognostication tool in peritoneal metastases (PM). We hypothesize that the distribution of PCI score and involvement of specific regions affects survival and morbidity outcomes.</p><p><strong>Methods: </strong>Data was collected from a prospective database of patients who underwent CRS and HIPEC for PM at the National Cancer Centre Singapore. We evaluate the relationship between PCI, PCI distribution, and survival and morbidity outcomes.</p><p><strong>Results: </strong>One hundred and fifty-two patients underwent CRS and HIPEC with a median PCI score of nine (range 0-31). Median overall survival (OS) and progression free survival (PFS) were 43 and 17 months, respectively. Region six (pelvis) was most commonly involved and had the highest frequency of heavy disease burden. Presence of PM in the lower abdomen, flanks, and small bowel were associated with poorer OS (p=0.01, 0.03, <0.001) and PFS (p=0.04, 0.02, <0.001). Involvement of porta hepatitis predicted poorer OS but not PFS (p=0.03). Involvement of the gastric antrum resulted in higher rates of postoperative complications.</p><p><strong>Conclusions: </strong>The pattern of PCI distribution may be associated with varying survival and morbidity outcomes.</p>","PeriodicalId":20231,"journal":{"name":"Pleura and Peritoneum","volume":"7 2","pages":"95-102"},"PeriodicalIF":1.4000,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166179/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pleura and Peritoneum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/pp-2021-0150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Objectives: Peritoneal cancer index (PCI) score is a common prognostication tool in peritoneal metastases (PM). We hypothesize that the distribution of PCI score and involvement of specific regions affects survival and morbidity outcomes.

Methods: Data was collected from a prospective database of patients who underwent CRS and HIPEC for PM at the National Cancer Centre Singapore. We evaluate the relationship between PCI, PCI distribution, and survival and morbidity outcomes.

Results: One hundred and fifty-two patients underwent CRS and HIPEC with a median PCI score of nine (range 0-31). Median overall survival (OS) and progression free survival (PFS) were 43 and 17 months, respectively. Region six (pelvis) was most commonly involved and had the highest frequency of heavy disease burden. Presence of PM in the lower abdomen, flanks, and small bowel were associated with poorer OS (p=0.01, 0.03, <0.001) and PFS (p=0.04, 0.02, <0.001). Involvement of porta hepatitis predicted poorer OS but not PFS (p=0.03). Involvement of the gastric antrum resulted in higher rates of postoperative complications.

Conclusions: The pattern of PCI distribution may be associated with varying survival and morbidity outcomes.

Abstract Image

Abstract Image

Abstract Image

腹膜癌指数分布对行细胞减缩手术及腹腔热化疗患者的影响。
目的:腹膜癌指数(PCI)评分是腹膜转移(PM)的常用预后工具。我们假设PCI评分的分布和特定区域的受累影响生存和发病率结果。方法:数据来自新加坡国家癌症中心接受CRS和HIPEC治疗PM患者的前瞻性数据库。我们评估了PCI、PCI分布、生存和发病率结果之间的关系。结果:152例患者接受了CRS和HIPEC, PCI评分中位数为9分(范围0-31)。中位总生存期(OS)和无进展生存期(PFS)分别为43个月和17个月。第6区(骨盆)最常受累,疾病负担重的频率最高。下腹部、侧腹和小肠存在PM与较差的OS相关(p=0.01, 0.03)。结论:PCI分布模式可能与不同的生存和发病率结果相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
11.10%
发文量
23
审稿时长
9 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信